This study is being conducted by the Centre for Anxiety, Attention-Deficit and Trauma
Lisdexamfetamine Dimesylate in the treatment of Adult ADHD with Anxiety Disorder Comorbidity
Purpose of the study
Individuals who suffer from Adult ADHD often suffer from other emotional or psychiatric disorders as well, including anxiety disorders and depression. Previous studies of treatments for Adult ADHD have focused on individuals who suffer from ADHD only. The purpose of this study is to examine the effect of a medication treatment for ADHD on both Adult ADHD as well as how it affects anxiety and mood disorders. Since it is quite common for individuals to have other disorders, it is important that clinicians understand what treatment options will be best for these people.
Who can join this study?
Adults aged 18 to 65 years, who think they may have ADHD (previous diagnosis not necessary; we will determine diagnosis) as well as anxiety or depression.
What does this study involve?
This study involves undergoing an interview assessment to see if your symptoms may fit the study criteria. If you so, and you provide your consent to participate, this study involves taking medication for Adult ADHD on a daily basis. The study will last for a total period 18 weeks and you will be asked to attend 13 visits. You will be given the study medication (Lisdexamfetamine Dimesylate) for part of the study a placebo pill (that has no medication) for part of the study. Neither you, nor the study team will know if you are taking the medication or the placebo. You will meet with a study doctor and study team members at each visit. Visits involve completing questionnaires about your symptoms, having your blood pressure and pulse checked and discussing how you have been feeling.
Why should I join this study?
You and other people may receive benefits from any medical research. Such benefits include the possibility that your condition may improve and that this study may lead to the development of new treatment approach for other people who have ADHD and a mood or anxiety disorder.
How can I get more information about this study?
For information contact
-Beth at 289-396-4242; email: info@anxietyADDtreatment.com OR leave your name and contact information in the comment section below.